New: medytox

neosiki (25)in celltrion • 7 years ago
Short sellers switch to other Kosdaq-listed biotech stocks as Celltrion moves to Kospi
Biotech companies topped the short-selling chart of the secondary board on Feb. 8. About KRW 70.4 billion (USD 64.7 million) worth of Celltrion Healthcare shares, or about 14% of the overall…
Downvoting a post can decrease pending rewards and make it less visible. Common reasons:
Disagreement on rewards
Fraud or plagiarism
Hate speech or trolling
Miscategorized content or spam

Submit
$0.00
0

Short sellers switch to other Kosdaq-listed biotech stocks as Celltrion moves to Kospi